Novanta is trading at $134.31, down -4.31%, as broader market weakness points to a market-driven move; no clear Novanta-specific announcement explaining the decline was identified.
- Reuters reported renewed concern about AI spending and rising oil prices weighing on markets on October 22.
- The Nasdaq Composite fell 1.66% and the S&P 500 fell 0.95%, supporting a market-driven explanation rather than a confirmed company catalyst.